U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
RILOTUMUMAB
51WEW898IJ
Investigational
General
Names
8
Classification
4
Identifiers
10
Subunits
4
Related Substances
1
RILOTUMUMAB
51WEW898IJ
Investigational
General
Approval Year
Unknown
139,594
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
RILOTUMUMAB
Official Name
English
AMG 102
Code
English
IMMUNOGLOBULIN G2, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR) (HUMAN MONOCLONAL 2.12.1 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL 2.12.1 LIGHT CHAIN, DIMER
Common Name
English
AMG-102
Code
English
RILOTUMUMAB [USAN]
Common Name
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Classification
4
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of gastric cancer including gastroesophageal junction adenocarcinoma
FDA ORPHAN DRUG
369412
Positive
EU ORPHAN DRUG
Positive
treatment of gastric cancer
EU-Orphan Drug
EU/3/14/1291
Showing 1 to 4 of 4 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
872514-65-3
PRIMARY
NCI_THESAURUS
C67079
PRIMARY
ChEMBL
CHEMBL1743063
PRIMARY
EVMPD
SUB33146
PRIMARY
DRUG BANK
DB11972
PRIMARY
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
51WEW898IJ
RILOTUMUMAB